PHK
ALBO

Point72 Hong Kong’s Albireo Pharma Inc ALBO Stock Holding History

Point72 Hong Kong’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,304
Closed -$64K – 1862
2022
Q3 		$64K Buy
+3,304
New +$68.3K ﹤0.01% 1357
2022
Q2 		– Sell
-662
Closed -$20K – 2556
2022
Q1 		$20K Sell
662
-19
-3% -$556 ﹤0.01% 1529
2021
Q4 		$16K Buy
+681
New +$18.1K ﹤0.01% 1582
2020
Q4 		– Sell
-381
Closed -$13K – 2129
2020
Q3 		$13K Buy
+381
New +$11.1K ﹤0.01% 955
2019
Q4 		– Sell
-56
Closed -$1K – 1533
2019
Q3 		$1K Buy
+56
New +$1.45K ﹤0.01% 932

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Point72 Hong Kong's ALBO Position: Q4 2022 in Review

Point72 Hong Kong sold out of Albireo Pharma Inc (ALBO) in Q4 2022, closing a stake of 3,304 shares — an estimated $64K sold.

Point72 Hong Kong first reported a position in ALBO in Q3 2019 and held it in 5 quarters. The position peaked at $64K in Q3 2022. 96 funds tracked by Wall St. Rank hold ALBO as of Q4 2022.

  • Point72 Hong Kong reported no remaining Albireo Pharma Inc position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 3,304 Albireo Pharma Inc shares in Q4 2022, an estimated $64K.
  • Point72 Hong Kong first reported a position in Albireo Pharma Inc in Q3 2019 and held it in 5 quarters.
  • Point72 Hong Kong's Albireo Pharma Inc position peaked at $64K in Q3 2022.
  • 96 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.